The association of lifetime insight and cognition in psychosis
Fecha
2015Versión
Acceso abierto / Sarbide irekia
Tipo
Artículo / Artikulua
Versión
Versión aceptada / Onetsi den bertsioa
Identificador del proyecto
Impacto
|
10.1016/j.schres.2014.12.019
Resumen
Poor insight has been related to poor course in psychosis. However, the role of cognition in insight remains
unclear.
The aim of this study was to examine the influence of cognition and lifetime psychopathological dimensions on
insight in psychosis. We followed up 42 patients with psychotic disorders over 10 years. Lifetime psychopathological dimensions and cognitive performance were assessed. ...
[++]
Poor insight has been related to poor course in psychosis. However, the role of cognition in insight remains
unclear.
The aim of this study was to examine the influence of cognition and lifetime psychopathological dimensions on
insight in psychosis. We followed up 42 patients with psychotic disorders over 10 years. Lifetime psychopathological dimensions and cognitive performance were assessed. Patients were divided into two groups by lifetime
patterns of insight and compared with 42 healthy volunteers.
Lower IQ and poorer social cognition were associated with higher risks of poorer lifetime insight of feeling ill and
global insight respectively. Lifetime negative symptoms were associated with a higher risk of poorer lifetime
insight into symptoms.
Lifetime lack of insight is independent of cognitive impairment in specific domains, except for social cognition.
Higher IQ may contribute to better lifetime awareness of illness, while better ability to manage emotions is
involved in lifetime global insight. [--]
Materias
Lifetime insight,
Psychosis,
Cognition,
Psychopathology
Editor
Elsevier
Publicado en
Schizophrenia Research 162(1-3), 2015, 183–188
Departamento
Universidad Pública de Navarra. Departamento de Ciencias de la Salud /
Nafarroako Unibertsitate Publikoa. Osasun Zientziak Saila
Versión del editor
Entidades Financiadoras
This work was supported by grants from the Government of Navarra (11/101 and 87/
2014) and the Carlos III Health Institute of the Spanish Economic Affairs and Competitiveness (ERDF Funds) (08/I/1026 and 11/02831).